Navigation Links
New UT Arlington research could improve pharmaceuticals testing
Date:4/30/2014

A UT Arlington chemistry professor, renowned for his work in the area of chemical separations, is leading an effort to find a more accurate way to measure water content in pharmaceuticals a major quality issue for drug manufacturers.

Daniel W. Armstrong, UT Arlington's Robert A. Welch Chair in Chemistry, says the new technique could be 100 times more sensitive than one of the most popular current methods.

"The analysis for water in many consumer products, including drugs, is one of the most required tests done in the world," said Armstrong. "Current methods have many shortcomings, including poor sensitivity and reproducibility; they cannot be used for all products and they can be time consuming. I believe our new 'ionic liquid' method offers improvements in all these areas."

Armstrong and two graduate students recently wrote about their new research in a paper that will be in the June issue of the Journal of Pharmaceutical and Biomedical Analysis. The publication describes using headspace gas chromatography and an ionic liquid gas chromatography column Armstrong's lab developed to measure moisture content in active pharmaceutical ingredients such as ibuprofen, tetracycline and ephedrine. Water content can affect the stability and shelf life of a drug and, when it is too high, cause microbial growth, according to the paper.

Chromatography is the process of separating a chemical mixture to measure its components. Headspace gas chromatography, or HSGC, involves the measuring of volatile analytes, or chemical components, as they diffuse into a "headspace" at the top of a tube of sample, including solids. The new method combines HSGC with the use of ionic liquids. Ionic liquids consist of a mixture of positively and negatively charged molecules. They have a variety of advantages as solvents.

Currently, two methods are most commonly used to measure moisture content. One is called weight loss on drying, or LOD; the other is called Karl Fischer Titration, or KFT. The newly described work from Armstrong's lab is useful on more types of drug ingredients than LOD and is more than 100 times more sensitive in some cases than KFT. It also can be used for much smaller samples and be automated, the paper said.

Graduate student Lillian A. Frink is lead author on the paper and Choyce A. Weatherly, also a graduate student in Armstong's lab, is a co-author.

"We think industry will utilize this method based on its broad applicability, its high accuracy, and the sample size requirements," said Frink. "It also doesn't have side-reactions like current methods, which make them inaccurate."

Armstrong has been a leader in the characterizing and synthesizing ionic liquids. He also holds patents on several open tubular capillary gas chromatography columns that utilize ionic liquids, including those used in the current research.

The newly published paper is called "Water determination in active pharmaceutical ingredients using ionic liquid headspace gas chromatography and two different detection protocols." It is available here: http://www.ncbi.nlm.nih.gov/pubmed/24561336.


'/>"/>

Contact: Traci Peterson
tpeterso@uta.edu
817-521-5494
University of Texas at Arlington
Source:Eurekalert

Related medicine news :

1. National Academy of Inventors names 4 UT Arlington professors as fellows
2. George Strait Tickets Dallas Arlington TX at the AT&T Stadium: Cheap Concert Tickets Reports Record Demand for King George's Final Concert in Dallas - Tickets Onsale 12/6
3. George Strait Tickets Dallas TX - AT&T Stadium: Ticket Down Reports Demand is through The Roof for George Strait Tickets in Arlington at AT&T Stadium (Cowboys Stadium)
4. UT Arlington professor will use NSF funds to reveal reactions inner workings
5. Dentist in Arlington, VA, Dr. Michael Rogers Launches New Website
6. Rich Dad Education to Hold 3-Day Financial Workshop in Arlington, VA on Aug. 23-25
7. UT Arlington researcher finds that money motivates employees to lose weight
8. Minimally Invasive SpineCARE® Opens Three New Clinics in Texas Branches out into Burleson, Arlington and Joshua
9. 7th Annual Reglera Reproductive Compliance Conference Slated for September 19-20, in Arlington, Virginia
10. Residence Inn Arlington Pentagon City Hotel Shows Strength With Unveiling of New Fitness Center
11. RE/MAX Suburban Brokers in Arlington Heights Plan June 8 Garage Sale to Benefit Lurie Children’s Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... ... Elemental LED, a leading U.S. based engineering and technology company that ... honored with Architectural SSL Product Innovation Awards (PIA) for the most innovative ... LED, provides a wide variety of superior quality linear, task, and accent LED lighting ...
(Date:8/17/2017)... ... August 17, 2017 , ... In its just released 2018 ... and Harry Nelson. This is the third consecutive year that Hardiman and Mills have ... were both recognized for expertise in Health Care Law while Mills was recognized in ...
(Date:8/17/2017)... ... August 17, 2017 , ... With the introduction of new devices, ... number of changes to the smartwatch market. As of June 2017, nearly nine percent ... the six months prior. Additionally, according to latest WEAR Report Industry Overview and Forecast ...
(Date:8/17/2017)... ... 17, 2017 , ... Momkus McCluskey Roberts LLC recently announced it ... member of the firm’s Commercial Litigation and Employment Law groups. , Ms. Parks joined ... in matters of employment litigation, commercial litigation and business disputes. Her experience includes all ...
(Date:8/17/2017)... , ... August 17, 2017 , ... ... Business Development Group, a Florida-based oncology business advisor to oncology practices, announced today ... the dollar amount of attributable savings from resolving critical clinical issues that would ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017 Diplomat Pharmacy, Inc. ... Michigan residents. Naloxone ... Flint retail pharmacy, G-3320 Beecher Road. ... the Food and Drug Administration, is intended to block ... slowed breathing, and loss of consciousness. The medication is ...
(Date:8/14/2017)... TIKVAH, Israel , Aug. 15, 2017 ... developer of adult stem cell technologies for neurodegenerative diseases, ... 30, 2017. "We ... pivotal Phase 3 trial to investigate NurOwn ® ... Chief Executive Officer of BrainStorm. "We have agreements with ...
(Date:8/8/2017)... --   Second-quarter 2017 revenues ... per share from continuing operations ... percent to $110 million ... $161 million Second-quarter 2017 ... increased 8 percent to $0.93 ...
Breaking Medicine Technology: